母胎医学会咨询系列第60号:体外受精妊娠的管理
本咨询讨论体外受精(IVF)妊娠的管理,指出IVF妊娠因早产和低出生体重风险增加而围产期不良结局风险升高,并基于现有证据给出12条推荐,涵盖遗传咨询、产前筛查与诊断、多胎减胎咨询、超声检查、胎儿超声心动图、胎盘与脐带评估、宫颈长度、胎儿生长评估、低剂量阿司匹林、产前胎儿监护及39周引产共同决策。
要点
- 建议所有接受或曾接受IVF(伴或不伴卵胞浆内单精子注射)的患者接受遗传咨询(GRADE 2C)。
- 推荐所有IVF妊娠患者无论是否做过胚胎植入前遗传学检测,均应获得产前遗传筛查及绒毛膜绒毛取样或羊膜腔穿刺诊断检测的选择(GRADE 1C)。
- 不推荐低剂量阿司匹林仅以IVF作为子痫前期预防的唯一指征;若存在1个或以上其他危险因素则推荐使用(GRADE 1B)。
核心结论
- IVF妊娠与早产和低出生体重所致围产期不良结局风险增加相关,本咨询基于现有证据给出IVF妊娠管理的12条推荐。
研究设计与样本
- 母胎医学会(Society for Maternal-Fetal Medicine)咨询系列第60号,基于现有证据提供推荐,未报告系统检索范围与样本量。
主要发现
- IVF妊娠主要因早产和低出生体重风险增加而围产期不良结局风险升高;多数辅助生殖技术妊娠为无并发症妊娠。
关键数值与推荐
- 建议所有接受或曾接受IVF(伴或不伴卵胞浆内单精子注射)的患者接受遗传咨询(GRADE 2C)。
- 推荐所有IVF妊娠患者无论是否已行胚胎植入前遗传学检测,均提供产前遗传筛查及绒毛膜绒毛取样或羊膜腔穿刺诊断检测的选择(GRADE 1C)。
- 推荐与接受或曾接受IVF的患者讨论包括无创产前检测(cell-free DNA)在内的早孕期筛查试验准确性(GRADE 1A)。
- 发生多胎妊娠时,推荐提供多胎妊娠减胎选择的咨询(GRADE 1C)。
- 推荐对IVF合并卵胞浆内单精子注射的妊娠行详细产科超声检查(CPT 76811)(GRADE 1B)。
临床怎么用
- 建议对IVF合并卵胞浆内单精子注射的妊娠提供胎儿超声心动图检查(GRADE 2C)。
- 推荐在详细胎儿解剖超声时仔细检查胎盘位置、胎盘形态和脐带插入部位,包括评估前置血管(GRADE 1B)。
- 推荐在18 0/7至22 6/7周解剖评估时经腹部或经阴道观察宫颈,但不推荐将连续宫颈长度评估作为IVF妊娠的常规实践(GRADE 1C)。
- 建议在第三孕期对IVF妊娠进行胎儿生长评估,但不推荐仅以IVF为唯一指征行连续生长超声(GRADE 2B)。
- 鉴于死胎风险增加,建议IVF妊娠自36 0/7周起开始每周产前胎儿监护(GRADE 2C);在缺乏专门针对IVF妊娠分娩时机研究的情况下,推荐患者与医疗保健提供者就39周妊娠引产进行共同决策(GRADE 1C)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The use of assisted reproductive technology has increased in the United States in the past several decades. Although most of these pregnancies are uncomplicated, in vitro fertilization is associated with an increased risk for adverse perinatal outcomes primarily caused by the increased risks of prematurity and low birthweight associated with in vitro fertilization pregnancies. This Consult discusses the management of pregnancies achieved with in vitro fertilization and provides recommendations based on the available evidence. The recommendations by the Society for Maternal-Fetal Medicine are as follows: (1) we suggest that genetic counseling be offered to all patients undergoing or who have undergone in vitro fertilization with or without intracytoplasmic sperm injection (GRADE 2C); (2) regardless of whether preimplantation genetic testing has been performed, we recommend that all patients who have achieved pregnancy with in vitro fertilization be offered the options of prenatal genetic screening and diagnostic testing via chorionic villus sampling or amniocentesis (GRADE 1C); (3) we recommend that the accuracy of first-trimester screening tests, including cell-free DNA for aneuploidy, be discussed with patients undergoing or who have undergone in vitro fertilization (GRADE 1A); (4) when multifetal pregnancies do occur, we recommend that counseling be offered regarding the option of multifetal pregnancy reduction (GRADE 1C); (5) we recommend that a detailed obstetrical ultrasound examination (CPT 76811) be performed for pregnancies achieved with in vitro fertilization and intracytoplasmic sperm injection (GRADE 1B); (6) we suggest that fetal echocardiography be offered to patients with pregnancies achieved with in vitro fertilization and intracytoplasmic sperm injection (GRADE 2C); (7) we recommend that a careful examination of the placental location, placental shape, and cord insertion site be performed at the time of the detailed fetal anatomy ultrasound, including evaluation for vasa previa (GRADE 1B); (8) although visualization of the cervix at the 18 0/7 to 22 6/7 weeks of gestation anatomy assessment with either a transabdominal or endovaginal approach is recommended, we do not recommend serial cervical length assessment as a routine practice for pregnancies achieved with in vitro fertilization (GRADE 1C); (9) we suggest that an assessment of fetal growth be performed in the third trimester for pregnancies achieved with in vitro fertilization; however, serial growth ultrasounds are not recommended for the sole indication of in vitro fertilization (GRADE 2B); (10) we do not recommend low-dose aspirin for patients with pregnancies achieved with IVF as the sole indication for preeclampsia prophylaxis; however, if 1 or more additional risk factors are present, low-dose aspirin is recommended (GRADE 1B); (11) given the increased risk for stillbirth, we suggest weekly antenatal fetal surveillance beginning by 36 0/7 weeks of gestation for pregnancies achieved with in vitro fertilization (GRADE 2C); (12) in the absence of studies focused specifically on timing of delivery for pregnancies achieved with IVF, we recommend shared decision-making between patients and healthcare providers when considering induction of labor at 39 weeks of gestation (GRADE 1C).
引用
- Ghidini A, Gandhi M, McCoy J, et al. Society for Maternal-Fetal Medicine Consult Series #60: Management of pregnancies resulting from in vitro fertilization. Am J Obstet Gynecol. 2021. PMID: 34736912. doi:10.1016/j.ajog.2021.11.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。